Rem Sleep On Fentanyl

Featured Health Expert
5949_2767
EXPERT

FDA Approves REMS for Transmucosal Immediate-Release Fentanyl Meds

Since 2007, the FDA has been discussing and debating the development of Risk Evaluation and Mitigation Strategies (REMS) for opioid medications.  The purpose of these REMS is to make access to opioid drugs more difficult for drug abusers while still giving chronic pain patients the ability to fill their prescriptions without undue problems.  Of course, that is more easily said than done.

Needless to say, since the idea of REMS was first announced, chronic pain patients have been concerned...

Read more

More information on "Rem Sleep On Fentanyl"

From Our Experts

See more SharePosts »

From Our Sources

More on Sleep Disorders »